| __timestamp | Johnson & Johnson | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8494000000 | 1271353000 |
| Thursday, January 1, 2015 | 9046000000 | 1620577000 |
| Friday, January 1, 2016 | 9095000000 | 2052295000 |
| Sunday, January 1, 2017 | 10554000000 | 2075142000 |
| Monday, January 1, 2018 | 10775000000 | 2186100000 |
| Tuesday, January 1, 2019 | 11355000000 | 3036600000 |
| Wednesday, January 1, 2020 | 12340000000 | 2735000000 |
| Friday, January 1, 2021 | 14277000000 | 2908100000 |
| Saturday, January 1, 2022 | 14135000000 | 3592500000 |
| Sunday, January 1, 2023 | 15048000000 | 4439000000 |
| Monday, January 1, 2024 | 17232000000 | 5132000000 |
Igniting the spark of knowledge
In the ever-evolving world of pharmaceuticals, innovation is key to staying ahead. Over the past decade, Johnson & Johnson and Regeneron Pharmaceuticals, Inc. have demonstrated their commitment to research and development (R&D) with significant investments. From 2014 to 2023, Johnson & Johnson consistently allocated a substantial portion of their budget to R&D, with a notable increase of approximately 77% over the period. In 2023, their R&D spending reached a peak, highlighting their dedication to pioneering healthcare solutions.
Regeneron Pharmaceuticals, Inc., while smaller in scale, has shown remarkable growth in R&D investment, with a staggering 250% increase from 2014 to 2023. This surge underscores their aggressive pursuit of innovation, particularly in biotechnology. As these two giants continue to prioritize R&D, the pharmaceutical landscape is set for groundbreaking advancements, promising a future of enhanced healthcare solutions.
Comparing Innovation Spending: Johnson & Johnson and AbbVie Inc.
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Biogen Inc.
Comparing Innovation Spending: Johnson & Johnson and Bio-Techne Corporation
Johnson & Johnson or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Insights: How Sanofi and Regeneron Pharmaceuticals, Inc. Allocate Funds
Research and Development Investment: Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Alpine Immune Sciences, Inc.
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs CRISPR Therapeutics AG
Regeneron Pharmaceuticals, Inc. or Bausch Health Companies Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Regeneron Pharmaceuticals, Inc. and HUTCHMED (China) Limited
Comparing Innovation Spending: Regeneron Pharmaceuticals, Inc. and Xencor, Inc.